We are live on ! Find out more
ZIVOW

Zivo Bioscience, Inc. Warrants

Delisted

ZIVOW was delisted on the 24th of November, 2023.

4 hedge funds and large institutions have $68K invested in Zivo Bioscience, Inc. Warrants in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

33% more funds holding

Funds holding: 34 (+1)

42% less capital invested

Capital invested by funds: $118K → $68K (-$50K)

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
WAM
1
Warberg Asset Management
Illinois
$40K +$11.4K +10,000 +33%
CH
2
CVI Holdings
Delaware
$17K -$36.4K -31,892 -66%
VCA
3
Verdence Capital Advisors
Maryland
$10K +$11.4K +10,000 New
UBS Group
4
UBS Group
Switzerland
$1K +$350 +307 +31%

ZIVOW Hedge Fund Activity: Q3 2021 in Review

4 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Warrants (ZIVOW) for Q3 2021, worth a combined $68K — down 42% from $118K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ZIVOW positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Verdence Capital Advisors, opening a new position worth an estimated $11.4K. The largest seller was CVI Holdings, cutting an estimated $36.4K.

  • 4 institutional investors held Zivo Bioscience, Inc. Warrants (ZIVOW) as of Q3 2021, up from 3 in Q2 2021.
  • Funds reported $68K of Zivo Bioscience, Inc. Warrants stock for Q3 2021, down 42% quarter-over-quarter.
  • 1 fund opened new Zivo Bioscience, Inc. Warrants positions in Q3 2021 and 0 closed out, a net change of +1 holder.
  • The largest Zivo Bioscience, Inc. Warrants buyer in Q3 2021 was Verdence Capital Advisors, an estimated $11.4K added.
  • The largest Zivo Bioscience, Inc. Warrants seller in Q3 2021 was CVI Holdings, an estimated $36.4K sold.

Based on aggregated 13F filings for Q3 2021.